Recently, our group demonstrated that epithelial-mesenchymal transition (EMT)-associated transcription factors ZEB1 and ZEB2 are potential targets for the regulation of self-renewal and tumorigenicity of canine mammary cancer cells11. This evidence concerns the gene ZEB2 and breast cancer.